Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou BioSyngen
Singapore, Singapore, Singapore
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
BioSyngen is a clinical-stage biotechnology company headquartered in Singapore and Guangzhou, specializing in the development of innovative T-cell therapies for solid tumors and hematological malignancies. The company leverages its proprietary platforms to identify specific T-cell receptors (TCRs) and develop next-generation cell therapies, including TCR-T and CAR-T treatments. Their lead programs target Epstein-Barr Virus (EBV)-associated cancers, such as nasopharyngeal carcinoma and lymphoma, with several candidates currently in Phase 1 and Phase 2 clinical trials globally. BioSyngen maintains a fully integrated value chain, encompassing R&D, clinical development, and GMP manufacturing capabilities.
- Therapeutic areas
- Oncology
- Modalities
- T cell receptor engineered T cell therapyCell therapyCAR-T cell therapy
- Industry
- Biotech
02
Partnerships
Agency for Science, Technology and Research (A*STAR)Sun Yat-sen University Cancer Center
Beyond the preview
Go deeper on Guangzhou BioSyngen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou BioSyngen.